Cancel
Muzammil Mansuri
Senior Strategic Advisor
@
Click Therapeutics
About Muzammil Mansuri
Muzammil Mansuri is a Senior Strategic Advisor and Venture Partner at F-Prime Capital, with extensive experience in executive roles at Sanofi, Gilead Sciences, and CGI Pharmaceuticals.
Known information
Muzammil Mansuri is a Senior Strategic Advisor and currently serves as a Venture Partner at F-Prime Capital. He has held significant executive positions, including Executive Vice President of Strategy, Business Development, and Licensing at Sanofi, and Senior Vice President of Research & Development Strategy and Corporate Development at Gilead Sciences. Mansuri was also the Chairman and CEO of CGI Pharmaceuticals, which was acquired by Gilead Sciences in 2010. His academic background includes post-doctoral positions at the University of California, Los Angeles (UCLA) and Columbia University. He began his career as a bench medicinal chemist with Bristol-Myers and holds a PhD in Organic Chemistry and a BS in Chemistry from University College London.
About Click Therapeutics
Click Therapeutics develops and commercializes software as prescription medical treatments, focusing on cognitive and neurobehavioral mechanisms to address unmet medical needs. Headquartered in New York, the company collaborates with major healthcare firms and has received significant funding and recognition for its innovative digital therapeutics.
Report inaccurate information
